Precision BioSciences, Inc. — Income Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$34M
R&D
$54M
D&A
$1M
Operating Income
$-52M
EBITDA
$-51M
Interest Expense
$1M
Interest Income
—
Other Income/Expense
$8M
Pretax Income
$-46M
Tax Provision
$0
Net Income
$-46M
Operating Margin
-152.2%
Net Margin
-133.4%
Effective Tax Rate
0.0%
Deferred Tax Assets
$1M
Deferred Tax Liabilities
$1M
DTA Valuation Allowance
$145M
Tax Credit Carryforwards
$36M
NOL Carryforwards
$74M
ETR (Continuing Operations)
0.0%
ETR Federal Statutory
21.0%
ETR State + Local (pp)
0.0%
Operating Lease Cost
$2M
Revenue YoY Variation
-50.1%
Income YoY Variation
-99.3%